Vitiligo is a dermatological condition that affects approximately 2% of the world’s population. It manifests as progressive loss of skin pigmentation due to the disappearance of melanocytes, the cells responsible for producing the skin’s natural color. Depigmentation usually appears on areas such as the face, limbs, and genital region.

Specialized Treatment in Cuba with Melagenina Plus®

Cuba offers an internationally recognized therapeutic alternative, developed at the Placental Histotherapy Center, which has over 30 years of experience in vitiligo treatment. The key component is Melagenina Plus®, a lotion derived from human placenta, which is applied daily to affected areas to stimulate the regeneration of melanocytes.

With a proven 86% effectiveness rate in skin repigmentation, this treatment is safe for patients of all ages and has no known side effects.

Personalized Medical Attention and Outpatient Program

The treatment is carried out on an outpatient basis over three consecutive days, from 8:30 a.m. to 4:00 p.m., and is supervised by a highly qualified team of medical professionals. Patients receive a comprehensive evaluation, clear guidance on the treatment process, and ongoing follow-up care.

This therapeutic option is part of the integrated offering of Servicios Médicos Cubanos, in alliance with the national biopharmaceutical industry, designed for those who choose Cuba as a destination to improve their health and access high-quality medical care.

How to Access the Treatment

To begin the process, you can contact the Coordination and Processing Center of the Cuban Medical Services Trading Company, S.A. by emailing smc@smcsalud.cu. You will receive detailed information, including the medical program and associated costs.

Servicios Médicos Cubanos reaffirms its commitment to patient health and well-being by offering innovative therapies that improve quality of life for people with dermatological conditions such as vitiligo.

By: MSc. Dr. Patricia Alonso Galbán
Marketing and Communication Specialist, CSMC, S.A.